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New treatment formulations for skin regeneration and wound infec-
tions have recently been the focus of research in the biomedical ﬁeld, as
they are one of the most common healthcare-associated infections.
Antimicrobial peptides (AMPs) are a class of small molecules that can
be used in the treatment of skin and wound infections as they occur as
part of the innate defense mechanism in many organisms, even in
microbes and virus, displaying immunomodulatory effects. With
advances in protein engineering and recombinant DNA technology, it is
now possible to reengineer protein-based materials with added func-
tionality. Indeed, recombinant DNA technology allows combining in the
same molecule distinct functionalities, leading to the production of a
chimeric protein displaying the properties of each block of amino acids.
With the aim of developing novel advanced materials and ultimately,
the fabrication of advanced medical devices, hereby we describe the
development, processing and characterization of a new recombinant
protein-based-polymer (rPBP) with antimicrobial activity. The func-
tional rPBP comprises a functional domain based on a synthetic cationic
AMP, fused in frame with an elastin-like-polymer consisting of 200
repeats of VPAVG (A200), as structural unit.
The functional polymer, processed into free standing ﬁlms by solvent
cast, was analyzed for its secondary structure by circular dichroism and
FT-IR and tested for their antimicrobial activity against different bacte-
rial and fungal species, in both ex vivo and in vitro conditions. For ex
vivo conditions, a new method was developed using pig skin as a
model. When in contact with the infected skin, the functionalized poly-
mer showed a good inhibition against the different microorganisms
tested after 3 h of contact with skin, indicating that AMP::A200 ﬁlms
are promising candidates for application in skin treatment and wound
infections. In addition, in vitro antimicrobial assays demonstrated that
the chimeric AMP::A200 polymer is a potent antimicrobial material
against a wide range of bacterial species, both gram positive and nega-
tive, as well as against yeast species. The antimicrobial activity was
dependent on the time of exposition and remarkably, in some cases,
almost 100% of microbial cell death was detected after 30 minutes
contact with the cast ﬁlms. Furthermore, the immunomodulatory
effects of the AMP::A200 for wound healing and are currently under-
way.
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